Detalles de la búsqueda
1.
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study.
AIDS Res Ther
; 16(1): 23, 2019 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-31464642
2.
NADPH oxidase and redox status in amygdala, hippocampus and cortex of male Wistar rats in an animal model of post-traumatic stress disorder.
Stress
; 21(6): 494-502, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29804499
3.
Effect of montelukast for treatment of asthma in cigarette smokers.
J Allergy Clin Immunol
; 131(3): 763-71, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23380218
4.
Week 96 efficacy and safety results of the phase 3, randomized EMERALD trial to evaluate switching from boosted-protease inhibitors plus emtricitabine/tenofovir disoproxil fumarate regimens to the once daily, single-tablet regimen of darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in treatment-experienced, virologically-suppressed adults living with HIV-1.
Antiviral Res
; 170: 104543, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279073
5.
Efficacy and safety of switching from boosted protease inhibitors plus emtricitabine and tenofovir disoproxil fumarate regimens to single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide at 48 weeks in adults with virologically suppressed HIV-1 (EMERALD): a phase 3, randomised, non-inferiority trial.
Lancet HIV
; 5(1): e23-e34, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28993180
6.
Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers.
J Clin Pharmacol
; 54(8): 949-57, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24644095
7.
Bioequivalence of a darunavir/cobicistat fixed-dose combination tablet versus single agents and food effect in healthy volunteers.
Antivir Ther
; 19(6): 597-606, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24964392
8.
Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect.
J Bone Miner Res
; 26(2): 242-51, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-20740685
Resultados
1 -
8
de 8
1
Próxima >
>>